Clenoliximab
Clenoliximab
Clenoliximab (pronounced: klen-oh-lix-i-mab) is a type of monoclonal antibody used in the treatment of certain medical conditions.
Etymology
The term "Clenoliximab" is derived from the International Nonproprietary Names (INN), where 'clen' refers to the target, 'lix' signifies the source, and 'mab' is an abbreviation for monoclonal antibody.
Usage
Clenoliximab is primarily used in the field of oncology for the treatment of certain types of cancer. It works by targeting specific cells and aiding the immune system in destroying those cells.
Related Terms
- Monoclonal Antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells.
- Oncology: The branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
- Cancer: A group of diseases characterized by the uncontrolled growth and spread of abnormal cells.
See Also
External links
- Medical encyclopedia article on Clenoliximab
- Wikipedia's article - Clenoliximab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski